Clinical trial
Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder
NCT03539900 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder
- Lead sponsor
- Yale University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 17, 2018
- Completion date
- March 22, 2023
- Enrollment
- 89 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.